Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...
After decades of stagnation in the schizophrenia field, Bristol Myers Squibb’s $14 billion deal for Karuna Therapeutics has ...
The path to discovering a blockbuster drug is often unpredictable. A promising molecule might be overlooked for decades, only ...
The Washington Post on MSN13d
FDA approves a novel drug for schizophrenia, a potential ‘game changer’Patients with schizophrenia are “all treated with pretty much the same medicines that work the same way,” Samit Hirawat, ...
A new type of schizophrenia drug developed by Boston biotech Karuna Therapeutics won approval from the U.S. Food and Drug ...
While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?
A drug-taking paranoid schizophrenic has been released having admitted two street robberies, after a judge said being locked ...
In a revealing Genomic Press Interview, Professor Illana Gozes discusses her groundbreaking work on activity-dependent ...
Murder accused Wire Reddington compared himself to Jesus and claimed to have absorbed the hurt and pain of his fellow inmates ...
Tommy Johnson, director of the state Department of Corrections and Rehabilitation, said the department is pivoting to new strategies to cope with mental health problems in Hawaii prisons and jails.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback